Menu
CLINICAL ASPECTS
Clinical presentationCLINICAL ASPECTS
Women & Pregnancy
 |
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |
|---|
|
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) |
|---|
|
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women... |
|---|
|
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn |
|---|
|
Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis |
|---|
|
What are the risks of COVID-19 infection in pregnant women? |
|---|
Pediatric patients
|
A retrospective study of the clinical characteristics of COVID-19 infection in 26 children |
|---|
|
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |
|---|
|
Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults |
|---|
|
Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases |
|---|
|
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China |
|---|
|
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus |
|---|
|
Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults |
|---|
|
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn |
|---|
|
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside... |
|---|
|
The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan, China |
|---|
Patients on Chronic Medicaments
|
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality |
|---|
|
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) |
|---|
|
Coronavirus: What People with Cancer Should Know |
|---|
|
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? |
|---|
|
Potential Effects of Coronaviruses on the Cardiovascular System: A Review |
|---|
|
Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer |
|---|
|
Risk of COVID-19 for cancer patients |
|---|
|
Risk of COVID-19 for patients with cancer |
|---|
|
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During ... |
|---|
Laboratory
|
A serological assay to detect SARS-CoV-2 seroconversion in humans |
|---|
|
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) |
|---|
|
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis |
|---|
|
Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis[v3] |
|---|
|
Coronavirus Disease 2019: Coronaviruses and Blood Safety |
|---|
|
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |
|---|
|
Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment |
|---|
|
Laboratory abnormalities in patients with COVID-2019 infection |
|---|
|
Opsonin and its mechanism of action in secondary immune response |
|---|
|
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) |
|---|
|
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory... |
|---|